Drug profile · INN
ritodrine hydrochloride
RITODRINE HYDROCHLORIDE
ritodrine hydrochloride (RITODRINE HYDROCHLORIDE) is a beta-2 adrenergic receptor agonist. Route of administration: injection. Current US regulatory status: approved.
Drug details — ritodrine hydrochloride
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
ritodrine hydrochloride (RITODRINE HYDROCHLORIDE) is a beta-2 adrenergic receptor agonist. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Beta-2 adrenergic receptor agonist
Primary target: Beta-2 adrenergic receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is ritodrine hydrochloride?
ritodrine hydrochloride (RITODRINE HYDROCHLORIDE) is a beta-2 adrenergic receptor agonist. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for ritodrine hydrochloride?
RITODRINE HYDROCHLORIDE is a marketed brand name for ritodrine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ritodrine hydrochloride?
ritodrine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.